Delcath Systems, Inc. (DCTH)
15.67
+0.31
(+2.02%)
USD |
NASDAQ |
Oct 12, 16:00
15.68
+0.01
(+0.06%)
After-Hours: 20:00
Delcath Systems EPS Diluted (Quarterly) : 0.0671 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0671 |
| March 31, 2026 | -0.0297 |
| December 31, 2025 | -0.052 |
| September 30, 2025 | 0.0207 |
| June 30, 2025 | 0.067 |
| March 31, 2025 | 0.0271 |
| December 31, 2024 | -0.1061 |
| September 30, 2024 | 0.0576 |
| June 30, 2024 | -0.4844 |
| March 31, 2024 | -0.4464 |
| December 31, 2023 | -0.4823 |
| September 30, 2023 | -1.139 |
| June 30, 2023 | -0.5778 |
| March 31, 2023 | -0.7744 |
| December 31, 2022 | -0.8582 |
| September 30, 2022 | -0.9632 |
| June 30, 2022 | -1.244 |
| March 31, 2022 | -1.099 |
| December 31, 2021 | -0.6859 |
| September 30, 2021 | -0.939 |
| June 30, 2021 | -0.9624 |
| March 31, 2021 | -1.038 |
| December 31, 2020 | -1.172 |
| September 30, 2020 | -1.164 |
| June 30, 2020 | -1.905 |
| Date | Value |
|---|---|
| March 31, 2020 | -108.07 |
| December 31, 2019 | 186.19 |
| September 30, 2019 | -986.44 |
| June 30, 2019 | -58.50 |
| March 31, 2019 | -75.11 |
| December 31, 2018 | -743.73 |
| September 30, 2018 | -173.34 |
| June 30, 2018 | -5084.08 |
| March 31, 2018 | 7629.37 |
| December 31, 2017 | -60611.89 |
| September 30, 2017 | -3.147M |
| June 30, 2017 | -943627.5 |
| March 31, 2017 | -30.86M |
| December 31, 2016 | -516.66M |
| September 30, 2016 | -80.93M |
| June 30, 2016 | -540.80M |
| March 31, 2016 | -152.65M |
| December 31, 2015 | -458.84M |
| September 30, 2015 | -240.71M |
| June 30, 2015 | -592.51M |
| March 31, 2015 | -629.92M |
| December 31, 2014 | -599.51M |
| September 30, 2014 | -945.96M |
| June 30, 2014 | -956.86M |
| March 31, 2014 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
| Baxter International, Inc. | 0.2432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.668M |
| Revenue (Quarterly) | 29.13M |
| Total Expenses (Quarterly) | 26.46M |
| Enterprise Value | 449.31M |
| Gross Profit Margin (Quarterly) | 89.75% |
| Profit Margin (Quarterly) | 9.16% |
| Earnings Yield | 0.04% |
| Normalized Earnings Yield | 0.0389 |